Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. Life-saving innovation to keep the world prepared for dangerous bacterial infections. Accelerate a diverse portfolio of innovative antibacterial products towards clinical development and regulatory approval with funding, expert support and cross-project initiatives. More awards and more funding was granted than in any year since the partnership was launched in The world urgently needs new treatments, as well as improved use and stewardship of existing antibiotics in humans and animals, to tackle the rising global threat of drug resistance. CARB-X is funding the best science around the world to accelerate the development of new antibiotics, vaccines, diagnostics and other life-saving products.